Global Biologic Therapeutic Drug Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Biologic Therapeutic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Monoclonal Antibodies
  • 1.2.3 Therapeutic Proteins
  • 1.2.4 Vaccines
• 1.3 Market by Application
  • 1.3.1 Global Biologic Therapeutic Drug Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Clinical Medicine
  • 1.3.3 Laboratory
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Biologic Therapeutic Drug Market Perspective (2016-2027)
• 2.2 Biologic Therapeutic Drug Growth Trends by Regions
  • 2.2.1 Biologic Therapeutic Drug Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Biologic Therapeutic Drug Historic Market Share by Regions (2016-2021)
  • 2.2.3 Biologic Therapeutic Drug Forecasted Market Size by Regions (2022-2027)
• 2.3 Biologic Therapeutic Drug Industry Dynamic
  • 2.3.1 Biologic Therapeutic Drug Market Trends
  • 2.3.2 Biologic Therapeutic Drug Market Drivers
  • 2.3.3 Biologic Therapeutic Drug Market Challenges
  • 2.3.4 Biologic Therapeutic Drug Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Biologic Therapeutic Drug Players by Revenue
  • 3.1.1 Global Top Biologic Therapeutic Drug Players by Revenue (2016-2021)
  • 3.1.2 Global Biologic Therapeutic Drug Revenue Market Share by Players (2016-2021)
• 3.2 Global Biologic Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Biologic Therapeutic Drug Revenue
• 3.4 Global Biologic Therapeutic Drug Market Concentration Ratio
  • 3.4.1 Global Biologic Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Biologic Therapeutic Drug Revenue in 2020
• 3.5 Biologic Therapeutic Drug Key Players Head office and Area Served
• 3.6 Key Players Biologic Therapeutic Drug Product Solution and Service
• 3.7 Date of Enter into Biologic Therapeutic Drug Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Biologic Therapeutic Drug Breakdown Data by Type

• 4.1 Global Biologic Therapeutic Drug Historic Market Size by Type (2016-2021)
• 4.2 Global Biologic Therapeutic Drug Forecasted Market Size by Type (2022-2027)

5 Biologic Therapeutic Drug Breakdown Data by Application

• 5.1 Global Biologic Therapeutic Drug Historic Market Size by Application (2016-2021)
• 5.2 Global Biologic Therapeutic Drug Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Biologic Therapeutic Drug Market Size (2016-2027)
• 6.2 North America Biologic Therapeutic Drug Market Size by Type
  • 6.2.1 North America Biologic Therapeutic Drug Market Size by Type (2016-2021)
  • 6.2.2 North America Biologic Therapeutic Drug Market Size by Type (2022-2027)
  • 6.2.3 North America Biologic Therapeutic Drug Market Size by Type (2016-2027)
• 6.3 North America Biologic Therapeutic Drug Market Size by Application
  • 6.3.1 North America Biologic Therapeutic Drug Market Size by Application (2016-2021)
  • 6.3.2 North America Biologic Therapeutic Drug Market Size by Application (2022-2027)
  • 6.3.3 North America Biologic Therapeutic Drug Market Size by Application (2016-2027)
• 6.4 North America Biologic Therapeutic Drug Market Size by Country
  • 6.4.1 North America Biologic Therapeutic Drug Market Size by Country (2016-2021)
  • 6.4.2 North America Biologic Therapeutic Drug Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Biologic Therapeutic Drug Market Size (2016-2027)
• 7.2 Europe Biologic Therapeutic Drug Market Size by Type
  • 7.2.1 Europe Biologic Therapeutic Drug Market Size by Type (2016-2021)
  • 7.2.2 Europe Biologic Therapeutic Drug Market Size by Type (2022-2027)
  • 7.2.3 Europe Biologic Therapeutic Drug Market Size by Type (2016-2027)
• 7.3 Europe Biologic Therapeutic Drug Market Size by Application
  • 7.3.1 Europe Biologic Therapeutic Drug Market Size by Application (2016-2021)
  • 7.3.2 Europe Biologic Therapeutic Drug Market Size by Application (2022-2027)
  • 7.3.3 Europe Biologic Therapeutic Drug Market Size by Application (2016-2027)
• 7.4 Europe Biologic Therapeutic Drug Market Size by Country
  • 7.4.1 Europe Biologic Therapeutic Drug Market Size by Country (2016-2021)
  • 7.4.2 Europe Biologic Therapeutic Drug Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Biologic Therapeutic Drug Market Size (2016-2027)
• 8.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Type
  • 8.2.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Application
  • 8.3.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Biologic Therapeutic Drug Market Size by Region
  • 8.4.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Biologic Therapeutic Drug Market Size (2016-2027)
• 9.2 Latin America Biologic Therapeutic Drug Market Size by Type
  • 9.2.1 Latin America Biologic Therapeutic Drug Market Size by Type (2016-2021)
  • 9.2.2 Latin America Biologic Therapeutic Drug Market Size by Type (2022-2027)
  • 9.2.3 Latin America Biologic Therapeutic Drug Market Size by Type (2016-2027)
• 9.3 Latin America Biologic Therapeutic Drug Market Size by Application
  • 9.3.1 Latin America Biologic Therapeutic Drug Market Size by Application (2016-2021)
  • 9.3.2 Latin America Biologic Therapeutic Drug Market Size by Application (2022-2027)
  • 9.3.3 Latin America Biologic Therapeutic Drug Market Size by Application (2016-2027)
• 9.4 Latin America Biologic Therapeutic Drug Market Size by Country
  • 9.4.1 Latin America Biologic Therapeutic Drug Market Size by Country (2016-2021)
  • 9.4.2 Latin America Biologic Therapeutic Drug Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Biologic Therapeutic Drug Market Size (2016-2027)
• 10.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Type
  • 10.2.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Application
  • 10.3.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Biologic Therapeutic Drug Market Size by Country
  • 10.4.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Aurobindo Pharma Ltd.
  • 11.1.1 Aurobindo Pharma Ltd. Company Details
  • 11.1.2 Aurobindo Pharma Ltd. Business Overview
  • 11.1.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Introduction
  • 11.1.4 Aurobindo Pharma Ltd. Revenue in Biologic Therapeutic Drug Business (2016-2021)
  • 11.1.5 Aurobindo Pharma Ltd. Recent Development
• 11.2 Concord Biotech
  • 11.2.1 Concord Biotech Company Details
  • 11.2.2 Concord Biotech Business Overview
  • 11.2.3 Concord Biotech Biologic Therapeutic Drug Introduction
  • 11.2.4 Concord Biotech Revenue in Biologic Therapeutic Drug Business (2016-2021)
  • 11.2.5 Concord Biotech Recent Development
• 11.3 GlaxoSmithKline Plc.
  • 11.3.1 GlaxoSmithKline Plc. Company Details
  • 11.3.2 GlaxoSmithKline Plc. Business Overview
  • 11.3.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Introduction
  • 11.3.4 GlaxoSmithKline Plc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
  • 11.3.5 GlaxoSmithKline Plc. Recent Development
• 11.4 H. Lundbeck A/S
  • 11.4.1 H. Lundbeck A/S Company Details
  • 11.4.2 H. Lundbeck A/S Business Overview
  • 11.4.3 H. Lundbeck A/S Biologic Therapeutic Drug Introduction
  • 11.4.4 H. Lundbeck A/S Revenue in Biologic Therapeutic Drug Business (2016-2021)
  • 11.4.5 H. Lundbeck A/S Recent Development
• 11.5 Novartis Global
  • 11.5.1 Novartis Global Company Details
  • 11.5.2 Novartis Global Business Overview
  • 11.5.3 Novartis Global Biologic Therapeutic Drug Introduction
  • 11.5.4 Novartis Global Revenue in Biologic Therapeutic Drug Business (2016-2021)
  • 11.5.5 Novartis Global Recent Development
• 11.6 Retractable Technologies, Inc.
  • 11.6.1 Retractable Technologies, Inc. Company Details
  • 11.6.2 Retractable Technologies, Inc. Business Overview
  • 11.6.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Introduction
  • 11.6.4 Retractable Technologies, Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
  • 11.6.5 Retractable Technologies, Inc. Recent Development
• 11.7 Smith Medical
  • 11.7.1 Smith Medical Company Details
  • 11.7.2 Smith Medical Business Overview
  • 11.7.3 Smith Medical Biologic Therapeutic Drug Introduction
  • 11.7.4 Smith Medical Revenue in Biologic Therapeutic Drug Business (2016-2021)
  • 11.7.5 Smith Medical Recent Development
• 11.8 AstraZeneca
  • 11.8.1 AstraZeneca Company Details
  • 11.8.2 AstraZeneca Business Overview
  • 11.8.3 AstraZeneca Biologic Therapeutic Drug Introduction
  • 11.8.4 AstraZeneca Revenue in Biologic Therapeutic Drug Business (2016-2021)
  • 11.8.5 AstraZeneca Recent Development
• 11.9 Pfizer Inc.
  • 11.9.1 Pfizer Inc. Company Details
  • 11.9.2 Pfizer Inc. Business Overview
  • 11.9.3 Pfizer Inc. Biologic Therapeutic Drug Introduction
  • 11.9.4 Pfizer Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
  • 11.9.5 Pfizer Inc. Recent Development
• 11.10 Merck and Co. Inc.
  • 11.10.1 Merck and Co. Inc. Company Details
  • 11.10.2 Merck and Co. Inc. Business Overview
  • 11.10.3 Merck and Co. Inc. Biologic Therapeutic Drug Introduction
  • 11.10.4 Merck and Co. Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
  • 11.10.5 Merck and Co. Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer